Aaron Welch, Ph.D.
Owner
Aaron Welch is the owner of CardioMender Wellness & Weight Loss Specialists and brings an unusually broad scientific and financial background to healthcare. He earned his Ph.D. in Molecular and Cellular Biology from The Johns Hopkins University, one of the world's leading biomedical research institutions, where his doctoral work focused on the molecular mechanisms underlying human disease. Following his training, Aaron transitioned into the capital markets, building a career as a biotechnology equity analyst and venture investor. He covered a large universe of clinical-stage and commercial biopharmaceutical companies at institutional firms including H.C. Wainwright & Co. and Guggenheim Securities, and later served as a portfolio manager at Symbiosis Capital Management, a healthcare-focused investment fund. In that capacity he evaluated hundreds of drug development programs, clinical trial datasets, and healthcare business models — developing a rigorous, evidence-based lens through which he assesses new therapies and patient care strategies. Aaron also founded Saber Therapeutics, a gene editing company developing meganuclease-based treatments for genetic disease, and PreFeast, a nutraceutical startup focused on metabolic health. His scientific fluency, capital markets experience, and entrepreneurial drive are reflected in CardioMender's commitment to offering patients access to the most current, evidence-supported approaches to medically supervised weight loss.